Adaptive Extracorporeal Blood Treatment Systems for Niche Environments

Publication ID: 24-11857715_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptive Extracorporeal Blood Treatment Systems for Niche Environments,” Published Technical Disclosure No. 24-11857715_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857715_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,715.

Summary of the Inventive Concept

A family of extracorporeal blood treatment systems tailored for specific, high-stakes environments, including high-security facilities, disaster relief scenarios, extreme weather conditions, and areas with limited medical resources.

Background and Problem Solved

The original patent disclosed an extracorporeal blood treatment apparatus with a blood-warming device. However, this design lacks adaptability for unique operational environments. The new inventive concept addresses this limitation by introducing specialized variations of the apparatus, ensuring reliable and efficient blood treatment in challenging situations.

Detailed Description of the Inventive Concept

The new claims describe four distinct embodiments: 1) a high-security system with tamper-evident sensors; 2) a disaster relief method using portable, battery-powered energy sources; 3) a portable apparatus for extreme weather conditions, housed in a waterproof and insulated casing; and 4) a system for areas with limited medical resources, featuring a simplified user interface and automated priming and calibration procedures. Each embodiment leverages the core concept of the original patent while incorporating innovative modifications to address specific niche requirements.

Novelty and Inventive Step

The new claims introduce novel features and combinations that are not obvious from the original patent, such as tamper-evident sensors, portable energy sources, and simplified user interfaces. These inventive steps provide a significant advancement in extracorporeal blood treatment technology, enabling reliable and efficient treatment in previously underserved environments.

Alternative Embodiments and Variations

Alternative embodiments could include integrating advanced sensors for real-time monitoring, incorporating artificial intelligence for predictive maintenance, or designing modular systems for easy transportation and deployment. These variations would further expand the inventive concept's scope and adaptability.

Potential Commercial Applications and Market

The adaptive extracorporeal blood treatment systems have significant commercial potential in various industries, including healthcare, disaster relief, and military operations. Target markets include high-security facilities, emergency response organizations, and medical providers operating in challenging environments.

CPC Classifications

SectionClassGroup
A A61 A61M1/369
A A61 A61M1/3623
A A61 A61M1/3626
A A61 A61M1/3627
A A61 A61M1/3643
A A61 A61M39/28
A A61 A61M2205/3344
A A61 A61M2205/36

Field of Art

Medical device engineering, specifically extracorporeal blood treatment systems, involving complex medical apparatus design, thermal management, fluid handling, and patient safety technologies

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with advanced degree, 3-5 years experience in medical device design, familiar with blood treatment technologies, regulatory standards, and modular medical system engineering

Obviousness Rationale

A PHOSITA would recognize that the published technical disclosure represents predictable variations on the source patent's core extracorporeal blood treatment apparatus design. The modifications address specific environmental constraints while maintaining the fundamental blood circuit and warming principles. These adaptations represent standard engineering problem-solving techniques applied to a known medical technology framework.

Obvious Combinations & Variations

Source Patent Element
Extracorporeal blood circuit with blood withdrawal and return lines including a heating zone
PTD Variation
Adding tamper-evident sensors to the blood return line for high-security environments
Obviousness Reasoning
Integrating security sensors is a known technique in medical device design, representing a predictable solution for protecting sensitive medical equipment with minimal technical complexity
Source Patent Element
Blood treatment apparatus with blood warmer
PTD Variation
Implementing portable battery-powered energy sources for disaster relief scenarios
Obviousness Reasoning
Adapting power systems for portable medical devices is a standard engineering approach, utilizing known battery and power management technologies to extend device functionality
Source Patent Element
Extracorporeal blood circuit with temperature management capabilities
PTD Variation
Developing waterproof and insulated casing for extreme weather conditions
Obviousness Reasoning
Environmental protection through specialized enclosures represents a routine design modification for medical equipment, applying standard materials science and protective engineering principles
Source Patent Element
Blood treatment apparatus with control mechanisms
PTD Variation
Implementing simplified user interface and automated priming procedures
Obviousness Reasoning
User interface simplification and automation are predictable improvements in medical device design, representing standard human factors engineering approaches
Source Patent Element
Blood treatment system with sterilization requirements
PTD Variation
Using ultraviolet light and hydrogen peroxide gas for comprehensive sterilization in high-security environments
Obviousness Reasoning
Combining multiple sterilization techniques is a known method in medical device processing, representing a predictable solution for enhanced contamination prevention
35 U.S.C. § 103 Summary: Based on US Patent 11857715, the present published technical disclosure demonstrates that the claimed variations in extracorporeal blood treatment apparatus design would have been obvious to a person having ordinary skill in the art at the time of invention. The disclosed modifications represent routine engineering adaptations applying known techniques to a established medical device technology framework, thereby rendering potential derivative claims non-patentable under standard obviousness analysis.

Original Patent Information

Patent NumberUS 11,857,715
TitleExtracorporeal blood treatment apparatus
Assignee(s)Gambro Lundia AB